LASEROPTEK Co., Ltd. receives FDA 510 (k) with extended aesthetic indications for its PicoLO ™ Nd: YAG picosecond laser



PicoLO, a non-invasive laser skin care system, has received 510 (k) clearance from the FDA to expand its capabilities in the treatment and treatment of benign pigmented lesions, acne scars and wrinkles.

Nd: YAG True Picosecond Pulse Laser with Extended Indications for the Treatment of Benign Pigmented Lesions, Acne Scars and Wrinkles

PicoLO’s new 510 (k) with extended cosmetic indications opens the door to cost-effective and advanced picosecond pulse laser skin rejuvenation treatments.

– Dr William Philip Werschler, Spokane Dermatology and Werschler Aesthetics

SEOUL, SOUTH KOREA, April 27, 2021 /EINPresswire.com/ – LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology applications, is pleased to announce that it has received 510 (k) clearance from the Food and Drug United States Administration (FDA). indications for his PicoLO ™ picosecond pulse Nd: YAG laser to include treatment of benign pigmented lesions, acne scars and wrinkles.

This 510 (k) clearance represents an important step in the evolution of PicoLO as a world-class picosecond pulse Nd: YAG laser delivering powerful and consistent photoacoustic-generated laser-induced optical ventilation (LIOB) in the skin to fracture. quickly and efficiently and finely fragment artificial and natural pigments such as tattoos and benign pigmented lesions. PicoLO’s unique handpiece technology, combined with industry-leading energy and pulse duration stability, provides clinicians with the ability to selectively deliver LIOB to the dermis, upper dermis and epidermis as desired . This LIOB depth control allows targeted micro-injuries; catalyze the body’s wound healing response thereby facilitating neocollagenesis and neoelastinogenesis which safely and effectively reduce the appearance of scars and wrinkles.

LASEROPTEK President and CEO CJ Lee said, “The new FDA approved indications for benign pigmented lesions, acne scars and wrinkles, added to PicoLO’s current indication for tattoo removal , mark PicoLO’s substantial progress in creating new opportunities for American clinicians. range of safe, comfortable and effective cosmetic laser procedures. This is yet another testament to our commitment to advancing the development of laser-based energetic devices that bring value to dermatologists, plastic surgeons, aesthetic physicians and their patients globally, ”added Mr. Lee. .

Dr William Philip Werschler, MD, FAAD, commented: “PicoLO’s new 510 (k) with expanded cosmetic indications opens the door to advanced and cost-effective picosecond laser skin rejuvenation treatments. We are excited to be working with LASEROPTEK to provide PicoLO procedures to our patients at Spokane Dermatology and Werschler Aesthetics. ”

To learn more about PicoLO and the complete LASEROPTEK aesthetic and medical dermatology laser system suite, please contact Jayson Jonsson of Gale Force Aesthetics, LLC at +1 (925) 705-6206 or visit www.laseroptek.com.

About LASEROPTEK Co., Ltd.
LASEROPTEK is a technology-driven global medical device company focused on aesthetic and medical lasers. Founded in 2000 and with in-house research and development capabilities, LASEROPTEK develops, manufactures and markets safe, stable, high-quality laser systems that combine advanced laser technology with clinical efficiency.

Media contacts:
Helena lee
Marketing director
+82 2-2135-1990
[email protected]

Christopher Dalton
Vice president
+1 (619) 609-4757
[email protected]
Visit us on social networks:
Facebook
LinkedIn



Source link

Previous Pakistani art export booms amid Covid - art & culture
Next Who is Christina Trevanion on Bargain Hunt?